Free Trial

GENinCode (GENI) Competitors

GENinCode logo
GBX 1.50 +0.10 (+7.14%)
As of 10:40 AM Eastern

GENI vs. DIS, AMC, LION, SPHR, GVC, TKO, SONG, NFC, MCS, and RDI

Should you be buying GENinCode stock or one of its competitors? The main competitors of GENinCode include Distil (DIS), Amur Minerals (AMC), Lionsgold (LION), Sphere Medical (SPHR), Entain PLC (GVC.L) (GVC), Taseko Mines (TKO), Hipgnosis Songs (SONG), Next Fifteen Communications Group (NFC), McCarthy & Stone (MCS), and Rdi Reit (RDI). These companies are all part of the "entertainment" industry.

GENinCode vs. Its Competitors

Distil (LON:DIS) and GENinCode (LON:GENI) are both small-cap entertainment companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership.

Distil has a beta of 0.61, suggesting that its share price is 39% less volatile than the S&P 500. Comparatively, GENinCode has a beta of 0.66, suggesting that its share price is 34% less volatile than the S&P 500.

Distil has a net margin of -109.66% compared to GENinCode's net margin of -228.70%. Distil's return on equity of -22.94% beat GENinCode's return on equity.

Company Net Margins Return on Equity Return on Assets
Distil-109.66% -22.94% -7.50%
GENinCode -228.70%-289.74%-63.99%

Distil has higher earnings, but lower revenue than GENinCode. Distil is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Distil£2.00M2.02-£2.19M-£0.13-1.96
GENinCode£2.67M1.00-£6.10M-£3.43-0.44

0.0% of Distil shares are held by institutional investors. Comparatively, 47.6% of GENinCode shares are held by institutional investors. 60.2% of Distil shares are held by company insiders. Comparatively, 39.8% of GENinCode shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Distil's average media sentiment score of 1.27 beat GENinCode's score of -0.40 indicating that Distil is being referred to more favorably in the media.

Company Overall Sentiment
Distil Positive
GENinCode Neutral

Summary

Distil beats GENinCode on 8 of the 12 factors compared between the two stocks.

Get GENinCode News Delivered to You Automatically

Sign up to receive the latest news and ratings for GENI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GENI vs. The Competition

MetricGENinCodeDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£2.66M£1.15B£5.74B£3.17B
Dividend YieldN/A5.44%3.95%5.04%
P/E Ratio-0.442.2831.37169.17
Price / Sales1.00473.82430.58464,912.68
Price / Cash0.8311.4237.7527.93
Price / Book0.922.5710.596.93
Net Income-£6.10M£334.07B£3.27B£5.89B
7 Day Performance5.26%1.21%0.91%0.31%
1 Month Performance-24.43%8.69%5.56%50.06%
1 Year Performance-77.78%3.17%50.64%154.03%

GENinCode Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GENI
GENinCode
N/AGBX 1.50
+7.1%
N/A-81.3%£2.66M£2.67M-0.442,300
DIS
Distil
N/AGBX 0.22
+10.0%
N/A-22.2%£3.41M£2.00M-1.66220,000
AMC
Amur Minerals
N/AN/AN/AN/A£1.25MN/A-8.7533,700
LION
Lionsgold
N/AN/AN/AN/A£0.00N/A0.002,021
SPHR
Sphere Medical
N/AN/AN/AN/A£0.00N/A0.0010,900Gap Up
High Trading Volume
GVC
Entain PLC (GVC.L)
N/AN/AN/AN/A£6.08B£3.40B-38.7913,345
TKO
Taseko Mines
1.4461 of 5 stars
GBX 234
+2.2%
GBX 307.50
+31.4%
+39.5%£1.27B£1.18B15.17N/ANews Coverage
SONG
Hipgnosis Songs
N/AN/AN/AN/A£1.23B£124.41M-1,131.111
NFC
Next Fifteen Communications Group
N/AN/AN/AN/A£787.02M£602.53M-974.3912,800Gap Up
MCS
McCarthy & Stone
N/AN/AN/AN/A£644.25M£621.43M21.397,500High Trading Volume
RDI
Rdi Reit
N/AN/AN/AN/A£462.34M£68.40M-4.442,020

Related Companies and Tools


This page (LON:GENI) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners